Gary A. Scott writing on free thinking

How Exciting!

Beware when you hear, or think, these words.

We need “in-sights” to make good decisions, not “ex-cites”.

We each need to determine how we live our own individual lives.  If not, someone else will and those someone others usually do not have your best interests at heart. The results are usually not pretty. Various forces, government, big business, education, media, etc, all vie for the right to lead us (and usually cash in on the process).

Regretfully what they say is what is good or bad for them, not for you or me as individuals.

The main tool external forces use to motivate us is excitement. When we are excited, the quiet voices within that tell us where and what we should be are not easily heard. Excitement blinds our insight.

The power of a good democracy requires a continual stress between the Public (Middle Class ie. You and Me), Big Business and Big Brother. That tension is good when it stops any one of the forces from becoming too big.

When government and big business join their forces, democracy is diminished. The public loses trust.

A New York Times article “How the Sugar Industry Shifted Blame to Fat” gives an example.

The sugar industry paid scientists in the 1960s to play down the link between sugar and heart disease and promote saturated fat as the culprit instead, newly released historical documents show.

The documents show that a trade group called the Sugar Research Foundation, known today as the Sugar Association, paid three Harvard scientists the equivalent of about $50,000 in today’s dollars to publish a 1967 review of research on sugar, fat and heart disease.  The studies used in the review were handpicked by the sugar group, and the article, which was published in the prestigious New England Journal of Medicine, minimized the link between sugar and heart health and cast aspersions on the role of saturated fat.

One of those Harvard scientists went on to become the head of nutrition at the United States Department of Agriculture, where in 1977 he helped draft the forerunner to the federal government’s dietary guidelines.

For 50 years, millions of people have been led in a false direction by this integration of Big Business and Big Brother.

Who benefits from such subterfuge?

Two clues from the Wall Street Journal article “Epipen Maker Dispenses Outsize Pay”.  One clue is in executive pay of drug and biotech firms.

This article says that Mylan, (the company which has dramatically increased the price for Epipens), has the second-highest executive pay among all U.S. drug and biotech firms over the past five years, paying its top five managers a total of nearly $300 million.

Mylan paid three top executives a total of at least $70 million apiece over that five-year period. All three Mylan executives ranked among the 20 highest-paid in the drug industry over the five years, a distinction unmatched by any other company.

What can we do? Instead of letting mainstream media form our opinions, we need to use our experience, application of knowledge, and critical reasoning to create our own personal insights that guide us.

If we temper exciting information with our experience, we can gain insights that shows the right, most powerful direction for each of us.

Editor’s note: Gary A. Scott has been writing on global investments and business for almost 50 years. He conducts online workshops and seminars on natural health and wealth through his website, www.garyascott.com. He spends his time between his farm in North Carolina and his summer home in Florida.

Image: ©iStock.com/VisualCommunications

Get Your Free Digital Currencies Report Here

Sign up here for our free Truth & Plenty e-letter and we’ll immediately send you a FREE research report on Digital Currencies.

Three times weekly you’ll receive our very best ideas on how to become financially, geographically and intellectually independent.

Get Your Free Report on Digital Currencies

We will collect and handle your personal information in accordance with our Privacy Policy.
You can cancel your subscription at any time.